Zymeworks (ZYME) Other financing activities (2021 - 2026)

Zymeworks has reported Other financing activities for 6 years, with the latest figure at $8.7 million in Q1 2026.

• Quarterly Other financing activities rose 1029.15% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.9 million (up 1431.93% YoY) and the FY2025 annual result came in at $5.0 million, changed N/A from the prior year.
• Other financing activities climbed to $8.7 million in Q1 2026 per ZYME's latest filing, from $4.9 million in the prior quarter.
• Over five years, Other financing activities peaked at $8.7 million in Q1 2026 and troughed at -$2.7 million in Q3 2024.
• A 5-year average of $1.1 million and a median of $770000.0 in 2023 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2023 and 2024: Other financing activities surged 19771.43% in 2023, then sank 303.31% in 2024.
• Over 5 years, Other financing activities stood at -$116000.0 in 2022, then soared by 763.79% to $770000.0 in 2023, then tumbled by 122.6% to -$174000.0 in 2024, then jumped by 2913.22% to $4.9 million in 2025, then jumped by 78.08% to $8.7 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $8.7 million, $4.9 million, and $28000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.